[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642027":3},{"organization":4,"outcomesModule":7,"designInfo":19,"detailedDescription":11,"studyPopulation":11,"armGroups":25,"interventions":36,"overallOfficials":43,"centralContacts":48,"locations":57,"responsibleParty":76,"collaborators":79,"id":83,"slug":11,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":86,"acronym":87,"eligibilityCriteria":88,"healthyVolunteers":84,"sex":89,"minAge":90,"maxAge":91,"enrollmentInfo":92,"targetDuration":11,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":101,"overallStatus":104,"whyStopped":11,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"The University of Texas Health Science Center, Houston","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Time to detect spasticity from incidence of stroke",null,"From baseline to 24 months after stroke",[14,17],{"measure":15,"description":16,"timeFrame":12},"Time to referral for spasticity from incidence of stroke","Evaluate average time to referral to neurology or Physical Medicine \\& Rehabilitation (PM\\&R)",{"measure":18,"description":11,"timeFrame":12},"The time from incidence of stroke to Botulinum neurotoxin (BoNT) administration",{"allocation":20,"interventionModel":21,"interventionModelDescription":11,"primaryPurpose":22,"observationalModel":11,"timePerspective":11,"maskingInfo":23},"RANDOMIZED","PARALLEL","DIAGNOSTIC",{"masking":24,"maskingDescription":11,"whoMasked":11},"NONE",[26,31],{"label":27,"type":28,"description":11,"interventionNames":29},"Screener","EXPERIMENTAL",[30],"Other: Screener",{"label":32,"type":33,"description":11,"interventionNames":34},"Standard of care","ACTIVE_COMPARATOR",[35],"Other: Standard of care",[37,40],{"type":6,"name":27,"description":38,"armGroupLabels":39,"otherNames":11},"Participants will be screened for spasticity using the 2 question version of the Post-stroke Spasticity Monitoring Questionnaire (PSMQ) at 2 days after discharge, 2 weeks post stroke, 1 month post stroke, 3 months post stroke and every 3 months after for a total of 12 screenings across 24 months",[27],{"type":6,"name":32,"description":41,"armGroupLabels":42,"otherNames":11},"Observational data for the standard of care group will be obtained via phone every 3 months post stroke up to 24 months, utilizing the Standard of Care Group Questionnaire.",[32],[44],{"name":45,"affiliation":46,"role":47},"Sean I Savitz, MD","The University of Texas Health Science Center at Houston PO Box 20036","PRINCIPAL_INVESTIGATOR",[49,53],{"name":45,"role":50,"phone":51,"phoneExt":11,"email":52},"CONTACT","(713) 500-7083","Sean.I.Savitz@uth.tmc.edu",{"name":54,"role":50,"phone":55,"phoneExt":11,"email":56},"Harriet Sales","(713) 500-7037","harriet.mari.sales@uth.tmc.edu",[58],{"facility":46,"status":11,"city":59,"state":60,"zip":61,"country":62,"countryCode":63,"cosmosGeoPoint":64,"geoPoint":69,"contacts":70},"Houston","Texas","77030","United States","US",{"type":65,"coordinates":66},"Point",[67,68],-95.36327,29.76328,{"lat":68,"lon":67},[71,73],{"name":45,"role":50,"phone":72,"phoneExt":11,"email":52},"713-500-7083",{"name":74,"role":50,"phone":75,"phoneExt":11,"email":56},"Harriet M Sales","(713) 500-7849",{"type":47,"investigatorFullName":77,"investigatorTitle":78,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Sean Savitz","Professor",[80],{"name":81,"class":82},"AbbVie","INDUSTRY","100642027",false,"NCT07639632","Reduce Inefficiencies in Management of Spasticity","ReIMage","Inclusion Criteria:\n\n* Currently admitted for an acute hemorrhagic or ischemic stroke; recurrent stroke allowed if no spasticity at baseline\n* NIHSS score of \\> 0 on items 5 or 6 (required of at least 1 limb)\n* Willingness to participate in the study for 24 months\n* Able to sign consent form or availability of a legally authorized representative to sign\n* Able to read\u002Fwrite in English\n* Identified MD for follow up post hospitalization\n\nExclusion Criteria:\n\n* Botulinum toxin use for any indication within the past 12 weeks\n* Acute life threatening illness\n* Prior limb injury or neurological diagnosis that limited movement in the now affected limb(s)\n* Any terminal illness that would limit participation in study follow ups\n* Known spasticity or other movement disorders that impact tone","ALL","18 Years","80 Years",{"count":93,"type":94},80,"ESTIMATED","INTERVENTIONAL",[97],"NA","The purpose of this study is to evaluate the effectiveness of a spasticity screener and to determine if the spasticity screener results are useful to healthcare providers and impact clinical decision making",[100],"Stroke",[102,103],"acute ischemic stroke","intracerebral hemorrhage","NOT_YET_RECRUITING","2026-06-10",{"date":107,"type":108},"2026-06-12","ACTUAL",{"date":110,"type":94},"2026-06-15",{"date":112,"type":94},"2029-11-30",{"name":5,"class":6},1]